Evidence map›Paper›PMID 39272924›Full record

ArticleCancers2024

Mutation Spectrum Comparison between Benign Breast Lesion Cohort, Unselected Cancer Cohort and High-Risk Breast Cancer Cohort.

Ava Kwong, Cecilia Y S Ho, Henry C M Leung, Amy W S Leung, Chun-Hang Au, Edmond S K Ma

Abstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ava KwongDivision of Breast Surgery, Department of Surgery, The University of Hong Kong, Hong Kong SAR, China.
Cecilia Y S HoDepartment of Pathology, Division of Molecular Pathology, Hong Kong Sanatorium & Hospital, Hong Kong SAR, China.ORCID 0000-0001-6870-3587
Henry C M LeungDepartment of Pathology, Division of Molecular Pathology, Hong Kong Sanatorium & Hospital, Hong Kong SAR, China.
Amy W S LeungDepartment of Pathology, Division of Molecular Pathology, Hong Kong Sanatorium & Hospital, Hong Kong SAR, China.
Chun-Hang AuDepartment of Pathology, Division of Molecular Pathology, Hong Kong Sanatorium & Hospital, Hong Kong SAR, China.ORCID 0000-0002-1707-0991
Edmond S K MaHong Kong Hereditary Breast Cancer Family Registry, Hong Kong SAR, China.ORCID 0000-0002-1259-2205

Funding

Asian Fund for Cancer Research NADr. Ellen Li Charitable Foundation NAHealth and Medical Research Fund 03143406Hong Kong Hereditary Breast Cancer Family Registry NAKerry Kuok Foundation NA
6 · The paper itself

Abstract

Mutation study for high-risk breast and ovarian cancer (HBOC) has been extensively studied in patients of different ethnicities. Here we compared the germline mutation rate and mutation spectrum of patients (

Indexed as

BRCAChinesegermline mutationhereditary breast cancers

Identifiers

PMID39272924
PMCPMC11393947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.